Three large urban family planning clinics (FPCs) 
Introduction
The advent of nucleic acid amplification (NAA) tests for genital Chlamydia trachomatis infection, more sensitive than tests previously used and which can be used on urine samples, allows diagnosis of this often-asymptomatic infection. Opportunistic testing of women has been recommended to reduce the burden of long-term morbidity. 1, 2 This study aimed to determine the prevalence of genital C. trachomatis infection in women attending urban family planning clinics (FPCs) in Scotland and the implications of opportunistically offering urine testing and follow-up in the FPC to women attending, and to their male partners if acceptable.
Method
A random sample of women attending FPCs in Glasgow, Edinburgh and Aberdeen between November 2000 and June 2001 were invited by research nurses to consent to take part in the study. At each centre the recruitment target was an unbiased sample of 250 women aged <20, 20-24, 25-29 and 29 years. Sexual behaviour information was provided anonymously, a first void specimen of urine for testing was obtained and an anonymous study proforma completed. Women received their usual clinical care in the clinic. If an endocervical swab was taken in the course of routine clinical care (screening or symptomatology) a firstvoid urine was not obtained.
Laboratory testing was performed using the LCx probe system (Abbot Diagnostics Maidenhead, UK) (Glasgow and Edinburgh FPCs) and the Probetec Chlamydia trachomatis amplified DNA assay (Becton Dickinson, Oxford, UK) (Aberdeen FPC) according to the manufacturers' instructions.
As is normal clinical practice, women were informed of the test result. Up to three reminders were sent to those with positive tests to tell them of the need for further advice, treatment and partner follow-up, the latter being available at the FPC if requested. Women with positive tests and attending partners were counselled and treated with azithromycin 1 g stat. Partners were also offered a urine test. The women provided information about treatment of other partners elsewhere.
All variables collected were examined as potential risk factors for infection by univariate logistic regression. Those factors found significant were then examined in a multivariate logistic regression. Analyses were performed using the Statistical Products and Software Solutions (SPSS, Chicago, IL, USA).
Ethical committees' approval was obtained for the study.
Results
Ninety-eight percent (3029/3094) of women accepted the test. Refusal rates were similar and low in all age groups. Reasons given for refusal included: self-perception of low risk because of steady relationship or no current partner, recent/previous chlamydia test, unwilling to give urine specimen at this appointment, and upset because of positive pregnancy test.
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The prevalence of infection was 5.2% (159/3029) overall and decreased with age (p<0.0001) ( Table 1 ). There was no significant difference in prevalence between centres. Significant differences in prevalence of infection (p<0.05) were also found by marital status, number of partners in last year, reason for attending the FPC, and signs/symptoms of genital infection.
Ninety-one percent (145/159) of positive women returned to the clinic for care. Of these, 91% (132/145) were intending to inform at least one partner of their infection status; women were less willing to inform previous partners. Only 57% (83/145) of women were screened for sexually transmitted infections (STIs) in the clinic and no woman was found to have an STI.
Eighty 'first-mentioned' partners of the 159 positive women (50%) were reported to have been treated for genital chlamydia infection. A total of 33 partners attended the FPC, 24 accepted a urine test and 14 tested positive.
The research nurses reported that pretest counselling and screening of the women took 10 minutes per woman on average and that counselling and management of a positive woman took 10 minutes. The latter estimate does not include time for STI screening of positive women or partner counselling and treatment.
Discussion
The very high acceptance rate demonstrates the acceptability of opportunistic testing in the FPC setting. The overall prevalence of 5.2% is comparable with recently published Scottish data based on NNA tests. 3, 4 The reasons given by women for refusing the offer of a test and their unwillingness to inform all partners demonstrated that much work remains to be done to inform women and men about genital chlamydia and to help them act to protect themselves from the infection and its sequelae. There is also strong support for the argument that men should be screened, 5 especially in view of women's reluctance to inform previous partners of their infection and the high proportion of male partners who were tested at the FPC and found to be positive.
FPC staff members already have skills in sexual behaviour counselling and in gynaecology. It is also encouraging that some male partners are willing to be treated in these clinics. The notion of 'unisex' care is an attractive one with the added benefit of shared sexual health responsibility.
Opportunistic screening in the FPC for genital C. trachomatis infection in women and their partners can be feasible and effective only if there are additional resources for staff training and for counselling, for treatments, and for screening for and management of STI. The advent of integrated family planning and genitourinary medicine services will facilitate opportunistic testing of females and males within the same health care location.
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